Boston, MA -- (SBWire) -- 03/21/2013 --Crohn's disease is a form of inflammatory bowel disease (IBD) characterized by recurrent inflammation of all or part of the gastrointestinal tract (CDC, 2011). Globally, the incidence rates for Crohn's disease vary between 0.3 cases and 16.5 cases per 100,000 population, possibly indicative of an environmental influence in disease etiology (Economou et al., 2009). In the 10 major markets (the US, Canada, France, Germany, Italy, Spain, the UK, Japan, India, and China), GlobalData epidemiologists expect the incident cases of Crohn's disease to increase from 124,216 cases in 2012 to 140,561 cases in 2022 with an annual growth rate (AGR) of 1.32%. It is also expected that prevalent cases of Crohn's disease in the given markets will increase from 1,337,272 cases in 2012 to 1,481,386 cases in 2022 with an annual growth rate (AGR) of 1.08%. A major strength of this analysis is that the forecast methodology was consistent across the 10 major markets to allow for a meaningful comparison of the patient populations in each country.
View Full Report Details and Table of Contents
Scope
- The Crohn's disease EpiCast Report provides an overview of the risk factors and comorbidities associated with Crohn's disease, as well as global trends in incidence and prevalence in the 10 major markets (the US, Canada, France, Germany, Italy, Spain, the UK, Japan, India, and China).
- It also includes a 10-year epidemiological forecast of the incident and prevalent cases of Crohn's disease segmented by sex and age in these markets.
Reasons to Get This Report
- Develop business strategies by understanding the trends shaping and driving the global Crohn's disease market.
- Quantify patient populations in the global Crohn's disease market to improve product development, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the Crohn's disease gender and age groups that present the best opportunities for Crohn's disease therapeutics in each of the markets covered.
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
Browse all Pharmaceuticals research reports at Fast Market Research
You may also be interested in these related reports:
- EpiCast Report: Alzheimer's Disease - Epidemiology Forecast to 2022
- EpiCast Report: Dyslipidemia Epidemiology Forecast to 2022
- EpiCast Report: Multiple Sclerosis - Epidemiology Forecast to 2022
- EpiCast Report: Osteoporosis - Epidemiology Forecast to 2022
- EpiCast Report: Colorectal Cancer Epidemiology Forecast to 2022
- EpiCast Report: Seasonal Influenza Vaccines Epidemiology Forecast to 2022
- EpiCast Report: Human Immunodeficiency Virus - Epidemiology Forecast to 2022
- EpiCast Report: Chronic Heart Failure Epidemilogy Forecast to 2022
- EpiCast Report: Epilepsy - Epidemiology Forecast to 2022
- AAB-001 (bapineuzumab) (Alzheimer's disease) - Analysis and Forecasts to 2022
Market Report, "EpiCast Report: Crohn's Disease Epidemiology Forecast to 2022", Published
Recently published research from GlobalData, "EpiCast Report: Crohn's Disease Epidemiology Forecast to 2022", is now available at Fast Market Research